Recent advancements in brain health research have identified specific nutritional biomarkers in blood that correlate with the risk of cognitive decline and Alzheimer’s disease. Experts from Harvard highlight that these findings represent a significant shift in the ability to detect neurological risks at an earlier stage.
By analyzing these blood-based markers, researchers are developing new methods to assess cognitive health before clinical symptoms become apparent. This development is considered a crucial step forward in understanding the biological indicators of brain aging and provides a potential framework for earlier medical intervention.
In-depth summary · AI, neutral